January |
| ||||||
| Company | Headquarters | Ticker symbol | Type of financing | Shares/Units (M) | Amount raised (M) USD | Date announced |
| Abeona Therapeutics Inc. | Cleveland;Ohio;United States | XNCM:ABEO | Credit facility | 20 | 1/8/24 | |
| Atara Biotherapeutics Inc. | Thousand Oaks;California;United States | XNGS:ATRA | Registered direct offering | 27.27S | 15 | 1/8/24 |
| Avenue Therapeutics Inc. | Miami;Florida;United States | XNCM:ATXI | Warrant exercise | 16.5S | 5 | 1/5/24 |
| Betterlife Pharma Inc. | Vancouver;British Columbia;Canada | XCNQ:BETR | Private placement | 0.3 | 1/2/24 | |
| Biosenic SA | Mont-Saint-Guibert;Wallonia;Belgium | XBRU:BIOS | Convertible bonds facility | 0.3 | 1/9/24 | |
| C4 Therapeutics Inc. | Watertown;Massachusetts;United States | XNGS:CCCC | Stock purchase agreement | 25 | 1/5/24 | |
| Cellectis SA | New York City;New York;United States | XNMS:CLLS | Credit facility | 16.2 | 1/17/24 | |
| Clearmind Medicine Inc. | Toronto;Ontario;Canada | XCNQ:CMND | Registered direct offering | 1.5U | 2.4 | 1/11/24 |
| Defence Therapeutics Inc. | Vancouver;British Columbia;Canada | XCNQ:DTC | Private placement | 1/16/24 | ||
| Immunitybio Inc. | Culver City;California;United States | XNGS:IBRX | Royalty financing | 200 | 1/2/24 | |
| Immunitybio Inc. | Culver City;California;United States | XNGS:IBRX | Equity investment | 2.4S | 10 | 1/2/24 |
| Inventiva SAS | Daix;Bourgogne-Franche-Comté;France | XNMS:IVA | Loan agreement | 27.4 | 1/11/24 | |
| Journey Medical Corp. | Scottsdale;Arizona;United States | XNCM:DERM | Credit facility | 15 | 1/2/24 | |
| Mannkind Corp. | Westlake Village;California;United States | XNMS:MNKD | Royalty purchase agreement | 150 | 1/2/24 | |
| Nurexone Biologic Inc. | Toronto;Ontario;Canada | XTSX:NRX | Private placement | 7.1U | 1.5 | 1/5/24 |
| Opko Health Inc. | Miami;Florida;United States | XNGS:OPK | Convertible senior notes offering | 33.7 | 1/10/24 | |
| Opko Health Inc. | Miami;Florida;United States | XNGS:OPK | Private placement | 1/10/24 | ||
| Polypid Ltd. | Petah-Tikva;Central District;Israel | XNMS:PYPD | Private placement | 3.4S | 16.2 | 1/5/24 |
| Relay Therapeutics Inc. | Cambridge;Massachusetts;United States | XNMS:RLAY | Private placement | 2.5S | 30 | 1/8/24 |
| Vaxart Inc. | South San Francisco;California;United States | XNCM:VXRT | Registered direct offering | 15.4S | 10 | 1/16/24 |
| Verona Pharma plc | London;England;United Kingdom | XNMS:VRNA | Debt financing | 50 | 1/2/24 | |
| Zealand Pharma A/S | Copenhagen;Capital Region;Denmark | XNGS:ZEAL | Private placement | 214 | 1/9/24 | |